The new nasal vaccine only needs one dose and produces reliable immunity right at the site where the virus enters the body.

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

I was yesterday years old when I learned there was a wrong way to use [nasal spray] Flonase,” content creator Amber Guttilla ...